News

After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
If you're one of the millions of Americans who have used or thought about using GLP-1 weight-loss drugs, it’s important to ...
Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...
Explore more
Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...
Menopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...
GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...